Industry Growth Insights published a new data on “Infectious Disease Point of Care Diagnostics Market”. The research report is titled “Infectious Disease Point of Care Diagnostics Market research by Types (Over-the-counter (OTC) Testing Kits, Prescription-based Testing Kits), By Applications (Bacterial Infections, Fungal Infection, Virus Infection, Cardiovascular Infection, Gastrointestinal Infection, Sexually Transmitted Disease (STD) Infection, Central Nervous System Infection, Other), By Players/Companies Abbott, Siemens, GE Healthcare, Accriva, Terumo, BioMerieux, Diasorin, Roche, Danaher Corporation, BD, Bio-Rad Laboratories, Cavidi, Cepheid, Diaxonhit, Eiken Chemical, EMD Millipore, Epitope Diagnostic, Euroimmun, Gold Standard Diagnostics, Hologic, Immunetics, InBios International”.
Scope Of The Report
Report Attributes
Report Details
Report Title
Infectious Disease Point of Care Diagnostics Market Research Report
By Type
Over-the-counter (OTC) Testing Kits, Prescription-based Testing Kits
By Application
Bacterial Infections, Fungal Infection, Virus Infection, Cardiovascular Infection, Gastrointestinal Infection, Sexually Transmitted Disease (STD) Infection, Central Nervous System Infection, Other
By Companies
Abbott, Siemens, GE Healthcare, Accriva, Terumo, BioMerieux, Diasorin, Roche, Danaher Corporation, BD, Bio-Rad Laboratories, Cavidi, Cepheid, Diaxonhit, Eiken Chemical, EMD Millipore, Epitope Diagnostic, Euroimmun, Gold Standard Diagnostics, Hologic, Immunetics, InBios International
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
218
Number of Tables & Figures
153
Customization Available
Yes, the report can be customized as per your need.
Global Infectious Disease Point of Care Diagnostics Market Report Segments:
The global Infectious Disease Point of Care Diagnostics market is segmented on the basis of:
Types
Over-the-counter (OTC) Testing Kits, Prescription-based Testing Kits
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Bacterial Infections, Fungal Infection, Virus Infection, Cardiovascular Infection, Gastrointestinal Infection, Sexually Transmitted Disease (STD) Infection, Central Nervous System Infection, Other
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- Abbott
- Siemens
- GE Healthcare
- Accriva
- Terumo
- BioMerieux
- Diasorin
- Roche
- Danaher Corporation
- BD
- Bio-Rad Laboratories
- Cavidi
- Cepheid
- Diaxonhit
- Eiken Chemical
- EMD Millipore
- Epitope Diagnostic
- Euroimmun
- Gold Standard Diagnostics
- Hologic
- Immunetics
- InBios International
Highlights of The Infectious Disease Point of Care Diagnostics Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- Over-the-counter (OTC) Testing Kits
- Prescription-based Testing Kits
- By Application:
- Bacterial Infections
- Fungal Infection
- Virus Infection
- Cardiovascular Infection
- Gastrointestinal Infection
- Sexually Transmitted Disease (STD) Infection
- Central Nervous System Infection
- Other
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the Infectious Disease Point of Care Diagnostics Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
Infectious Disease Point of Care Diagnostics is a type of diagnostic equipment that helps healthcare providers diagnose infectious diseases quickly and accurately. This technology can be used to test for the presence of specific viruses, bacteria, or parasites in body fluids or tissues. Infectious Disease Point of Care Diagnostics can also be used to identify the symptoms and causes of infections.
Some of the major companies in the infectious disease point of care diagnostics market are Abbott, Siemens, GE Healthcare, Accriva, Terumo, BioMerieux, Diasorin, Roche, Danaher Corporation, BD, Bio-Rad Laboratories, Cavidi, Cepheid, Diaxonhit, Eiken Chemical, EMD Millipore, Epitope Diagnostic, Euroimmun, Gold Standard Diagnostics, Hologic, Immunetics, InBios International.
Chapter 1 Executive Summary
Chapter 2 Assumptions and Acronyms Used
Chapter 3 Research Methodology
Chapter 4 Infectious Disease Point of Care Diagnostics Market Overview
4.1 Introduction
4.1.1 Market Taxonomy
4.1.2 Market Definition
4.1.3 Macro-Economic Factors Impacting the Market Growth
4.2 Infectious Disease Point of Care Diagnostics Market Dynamics
4.2.1 Market Drivers
4.2.2 Market Restraints
4.2.3 Market Opportunity
4.3 Infectious Disease Point of Care Diagnostics Market - Supply Chain Analysis
4.3.1 List of Key Suppliers
4.3.2 List of Key Distributors
4.3.3 List of Key Consumers
4.4 Key Forces Shaping the Infectious Disease Point of Care Diagnostics Market
4.4.1 Bargaining Power of Suppliers
4.4.2 Bargaining Power of Buyers
4.4.3 Threat of Substitution
4.4.4 Threat of New Entrants
4.4.5 Competitive Rivalry
4.5 Global Infectious Disease Point of Care Diagnostics Market Size & Forecast, 2018-2028
4.5.1 Infectious Disease Point of Care Diagnostics Market Size and Y-o-Y Growth
4.5.2 Infectious Disease Point of Care Diagnostics Market Absolute $ Opportunity
Chapter 5 Global Infectious Disease Point of Care Diagnostics Market Analysis and Forecast by Type
5.1 Introduction
5.1.1 Key Market Trends & Growth Opportunities by Type
5.1.2 Basis Point Share (BPS) Analysis by Type
5.1.3 Absolute $ Opportunity Assessment by Type
5.2 Infectious Disease Point of Care Diagnostics Market Size Forecast by Type
5.2.1 Over-the-counter (OTC) Testing Kits
5.2.2 Prescription-based Testing Kits
5.3 Market Attractiveness Analysis by Type
Chapter 6 Global Infectious Disease Point of Care Diagnostics Market Analysis and Forecast by Applications
6.1 Introduction
6.1.1 Key Market Trends & Growth Opportunities by Applications
6.1.2 Basis Point Share (BPS) Analysis by Applications
6.1.3 Absolute $ Opportunity Assessment by Applications
6.2 Infectious Disease Point of Care Diagnostics Market Size Forecast by Applications
6.2.1 Bacterial Infections
6.2.2 Fungal Infection
6.2.3 Virus Infection
6.2.4 Cardiovascular Infection
6.2.5 Gastrointestinal Infection
6.2.6 Sexually Transmitted Disease (STD) Infection
6.2.7 Central Nervous System Infection
6.2.8 Other
6.3 Market Attractiveness Analysis by Applications
Chapter 7 Global Infectious Disease Point of Care Diagnostics Market Analysis and Forecast by Region
7.1 Introduction
7.1.1 Key Market Trends & Growth Opportunities by Region
7.1.2 Basis Point Share (BPS) Analysis by Region
7.1.3 Absolute $ Opportunity Assessment by Region
7.2 Infectious Disease Point of Care Diagnostics Market Size Forecast by Region
7.2.1 North America
7.2.2 Europe
7.2.3 Asia Pacific
7.2.4 Latin America
7.2.5 Middle East & Africa (MEA)
7.3 Market Attractiveness Analysis by Region
Chapter 8 Coronavirus Disease (COVID-19) Impact
8.1 Introduction
8.2 Current & Future Impact Analysis
8.3 Economic Impact Analysis
8.4 Government Policies
8.5 Investment Scenario
Chapter 9 North America Infectious Disease Point of Care Diagnostics Analysis and Forecast
9.1 Introduction
9.2 North America Infectious Disease Point of Care Diagnostics Market Size Forecast by Country
9.2.1 U.S.
9.2.2 Canada
9.3 Basis Point Share (BPS) Analysis by Country
9.4 Absolute $ Opportunity Assessment by Country
9.5 Market Attractiveness Analysis by Country
9.6 North America Infectious Disease Point of Care Diagnostics Market Size Forecast by Type
9.6.1 Over-the-counter (OTC) Testing Kits
9.6.2 Prescription-based Testing Kits
9.7 Basis Point Share (BPS) Analysis by Type
9.8 Absolute $ Opportunity Assessment by Type
9.9 Market Attractiveness Analysis by Type
9.10 North America Infectious Disease Point of Care Diagnostics Market Size Forecast by Applications
9.10.1 Bacterial Infections
9.10.2 Fungal Infection
9.10.3 Virus Infection
9.10.4 Cardiovascular Infection
9.10.5 Gastrointestinal Infection
9.10.6 Sexually Transmitted Disease (STD) Infection
9.10.7 Central Nervous System Infection
9.10.8 Other
9.11 Basis Point Share (BPS) Analysis by Applications
9.12 Absolute $ Opportunity Assessment by Applications
9.13 Market Attractiveness Analysis by Applications
Chapter 10 Europe Infectious Disease Point of Care Diagnostics Analysis and Forecast
10.1 Introduction
10.2 Europe Infectious Disease Point of Care Diagnostics Market Size Forecast by Country
10.2.1 Germany
10.2.2 France
10.2.3 Italy
10.2.4 U.K.
10.2.5 Spain
10.2.6 Russia
10.2.7 Rest of Europe
10.3 Basis Point Share (BPS) Analysis by Country
10.4 Absolute $ Opportunity Assessment by Country
10.5 Market Attractiveness Analysis by Country
10.6 Europe Infectious Disease Point of Care Diagnostics Market Size Forecast by Type
10.6.1 Over-the-counter (OTC) Testing Kits
10.6.2 Prescription-based Testing Kits
10.7 Basis Point Share (BPS) Analysis by Type
10.8 Absolute $ Opportunity Assessment by Type
10.9 Market Attractiveness Analysis by Type
10.10 Europe Infectious Disease Point of Care Diagnostics Market Size Forecast by Applications
10.10.1 Bacterial Infections
10.10.2 Fungal Infection
10.10.3 Virus Infection
10.10.4 Cardiovascular Infection
10.10.5 Gastrointestinal Infection
10.10.6 Sexually Transmitted Disease (STD) Infection
10.10.7 Central Nervous System Infection
10.10.8 Other
10.11 Basis Point Share (BPS) Analysis by Applications
10.12 Absolute $ Opportunity Assessment by Applications
10.13 Market Attractiveness Analysis by Applications
Chapter 11 Asia Pacific Infectious Disease Point of Care Diagnostics Analysis and Forecast
11.1 Introduction
11.2 Asia Pacific Infectious Disease Point of Care Diagnostics Market Size Forecast by Country
11.2.1 China
11.2.2 Japan
11.2.3 South Korea
11.2.4 India
11.2.5 Australia
11.2.6 South East Asia (SEA)
11.2.7 Rest of Asia Pacific (APAC)
11.3 Basis Point Share (BPS) Analysis by Country
11.4 Absolute $ Opportunity Assessment by Country
11.5 Market Attractiveness Analysis by Country
11.6 Asia Pacific Infectious Disease Point of Care Diagnostics Market Size Forecast by Type
11.6.1 Over-the-counter (OTC) Testing Kits
11.6.2 Prescription-based Testing Kits
11.7 Basis Point Share (BPS) Analysis by Type
11.8 Absolute $ Opportunity Assessment by Type
11.9 Market Attractiveness Analysis by Type
11.10 Asia Pacific Infectious Disease Point of Care Diagnostics Market Size Forecast by Applications
11.10.1 Bacterial Infections
11.10.2 Fungal Infection
11.10.3 Virus Infection
11.10.4 Cardiovascular Infection
11.10.5 Gastrointestinal Infection
11.10.6 Sexually Transmitted Disease (STD) Infection
11.10.7 Central Nervous System Infection
11.10.8 Other
11.11 Basis Point Share (BPS) Analysis by Applications
11.12 Absolute $ Opportunity Assessment by Applications
11.13 Market Attractiveness Analysis by Applications
Chapter 12 Latin America Infectious Disease Point of Care Diagnostics Analysis and Forecast
12.1 Introduction
12.2 Latin America Infectious Disease Point of Care Diagnostics Market Size Forecast by Country
12.2.1 Brazil
12.2.2 Mexico
12.2.3 Rest of Latin America (LATAM)
12.3 Basis Point Share (BPS) Analysis by Country
12.4 Absolute $ Opportunity Assessment by Country
12.5 Market Attractiveness Analysis by Country
12.6 Latin America Infectious Disease Point of Care Diagnostics Market Size Forecast by Type
12.6.1 Over-the-counter (OTC) Testing Kits
12.6.2 Prescription-based Testing Kits
12.7 Basis Point Share (BPS) Analysis by Type
12.8 Absolute $ Opportunity Assessment by Type
12.9 Market Attractiveness Analysis by Type
12.10 Latin America Infectious Disease Point of Care Diagnostics Market Size Forecast by Applications
12.10.1 Bacterial Infections
12.10.2 Fungal Infection
12.10.3 Virus Infection
12.10.4 Cardiovascular Infection
12.10.5 Gastrointestinal Infection
12.10.6 Sexually Transmitted Disease (STD) Infection
12.10.7 Central Nervous System Infection
12.10.8 Other
12.11 Basis Point Share (BPS) Analysis by Applications
12.12 Absolute $ Opportunity Assessment by Applications
12.13 Market Attractiveness Analysis by Applications
Chapter 13 Middle East & Africa (MEA) Infectious Disease Point of Care Diagnostics Analysis and Forecast
13.1 Introduction
13.2 Middle East & Africa (MEA) Infectious Disease Point of Care Diagnostics Market Size Forecast by Country
13.2.1 Saudi Arabia
13.2.2 South Africa
13.2.3 UAE
13.2.4 Rest of Middle East & Africa (MEA)
13.3 Basis Point Share (BPS) Analysis by Country
13.4 Absolute $ Opportunity Assessment by Country
13.5 Market Attractiveness Analysis by Country
13.6 Middle East & Africa (MEA) Infectious Disease Point of Care Diagnostics Market Size Forecast by Type
13.6.1 Over-the-counter (OTC) Testing Kits
13.6.2 Prescription-based Testing Kits
13.7 Basis Point Share (BPS) Analysis by Type
13.8 Absolute $ Opportunity Assessment by Type
13.9 Market Attractiveness Analysis by Type
13.10 Middle East & Africa (MEA) Infectious Disease Point of Care Diagnostics Market Size Forecast by Applications
13.10.1 Bacterial Infections
13.10.2 Fungal Infection
13.10.3 Virus Infection
13.10.4 Cardiovascular Infection
13.10.5 Gastrointestinal Infection
13.10.6 Sexually Transmitted Disease (STD) Infection
13.10.7 Central Nervous System Infection
13.10.8 Other
13.11 Basis Point Share (BPS) Analysis by Applications
13.12 Absolute $ Opportunity Assessment by Applications
13.13 Market Attractiveness Analysis by Applications
Chapter 14 Competition Landscape
14.1 Infectious Disease Point of Care Diagnostics Market: Competitive Dashboard
14.2 Global Infectious Disease Point of Care Diagnostics Market: Market Share Analysis, 2019
14.3 Company Profiles (Details – Overview, Financials, Developments, Strategy)
14.3.1 Abbott
14.3.2 Siemens
14.3.3 GE Healthcare
14.3.4 Accriva
14.3.5 Terumo
14.3.6 BioMerieux
14.3.7 Diasorin
14.3.8 Roche
14.3.9 Danaher Corporation
14.3.10 BD
14.3.11 Bio-Rad Laboratories
14.3.12 Cavidi
14.3.13 Cepheid
14.3.14 Diaxonhit
14.3.15 Eiken Chemical
14.3.16 EMD Millipore
14.3.17 Epitope Diagnostic
14.3.18 Euroimmun
14.3.19 Gold Standard Diagnostics
14.3.20 Hologic
14.3.21 Immunetics
14.3.22 InBios International
